Gene-Editing Co. Cibus Delays IPO, Citing Market Conditions
Gene-editing company Cibus Global Ltd. cited market conditions in postponing its initial public offering Thursday, becoming the third company this week to pull IPO plans shortly before a scheduled pricing date....To view the full article, register now.
Already a subscriber? Click here to view full article